Biotech Offering Will Test Unsettled Markets

There is a tiny shred of good news for Lehman Brothers, the beleaguered investment bank: one of the investments of its Healthcare Venture Capital arm, a biotech company called Fluidigm, is set to go public this week. That is, if the markets... 2 months ago